Related Experiment Videos
Physiological rationale for co-treatment with diuretics in heart failure
1Department of Medicine, University of Minnesota Medical School, Minneapolis 55455.
British Heart Journal
|August 1, 1994
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Rationale for angiotensin II receptor blocker therapy in chronic heart failure.
Journal of the renin-angiotensin-aldosterone system : JRAAS·2007
Relationship between C-reactive protein and arterial stiffness in an asymptomatic population.
Journal of human hypertension·2005
Small and large artery elasticity indices in peripheral arterial occlusive disease (PAOD).
Vascular medicine (London, England)·2002
A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure.
The New England journal of medicine·2002
ACE inhibition and vascular remodeling of resistance vessels: vascular compliance and cardiovascular implications.
Heart disease (Hagerstown, Md.)·2001
Natural History and Treatment Outcomes of Congenital Thrombotic Thrombocytopenic Purpura: A Retrospective Longitudinal Cohort Study.
Journal of health economics and outcomes research·2026
Depression and Anxiety in Pulmonary Hypertension Associated With Congenital Heart Disease: Pathophysiology and Clinical Implications of the Heart-Brain Axis.
Journal of the Saudi Heart Association·2026
Personalizing Modern Heart Failure Therapy in HFrEF: Bridging Evidence, Clinical Practice, and Future Perspectives.
Journal of the Saudi Heart Association·2026
The effect of high-intensity interval training on cardiorespiratory fitness for non-ambulatory stroke survivors: a randomized controlled trial.
Frontiers in sports and active living·2026